Skip to main content
Premium Trial:

Request an Annual Quote

HTS Biosystems Opens Doors and Licenses Technologies from Ciencia

Premium

ST. PAUL, Minn.--HTS Biosystems, a new company that provides high-throughput molecular detection systems for pharmaceutical and genomics research, has entered into technology licensing and consulting agreements with Ciencia of Hartford, Conn.

 

Ciencia has licensed present and future technologies to HTS, including initial patents related to phase fluorescence that will be used in HTS’s Phase fluorescence detection system. Ciencia also will provide engineering analysis and design, instrumentation development, systems integration, and prototype fabrication services to HTS.

Filed under

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.